Positron Emission Tomography And Recovery following Revascularization: A Multi Centre, Randomized Trial of Evaluation of Outcome and Cost-Effectiveness using an F-18-fluorodeoxyglucose (FDG) PET-Guided Approach to Management of Patients with Coronary Disease and Severe LV Dysfunction (PARR Phase 2)

niversity of Ottawa Heart Institute (Canada)0 sites430 target enrollmentOctober 22, 2007

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Coronary artery disease, LV dysfunction, congestive heart failure
Sponsor: niversity of Ottawa Heart Institute (Canada)
Enrollment: 430
Status: Completed
Last Updated: 11 years ago

No summary available.

Registry

who.int

Start Date

October 22, 2007

End Date

TBD

Last Updated

11 years ago

Study Type

Interventional

Sex

All

Sponsor

niversity of Ottawa Heart Institute (Canada)

•1\. Age greater than or equal to 18 years, either sex
•2\. Coronary artery disease documented by coronary angiography, previous myocardial infarction (MI), previous revascularization procedure or positive exercise stress/perfusion imaging
•3\. Severely reduced LV function with ejection fraction (EF) less than or equal to 35% attributable to coronary disease
•4\. Any patient being considered for revascularization, transplant/heart failure work up or where in the opinion of the attending physician viability imaging would be considered useful in the ongoing clinical managements

•1\. Co\-morbid medical conditions likely to make survival for the duration of the study unlikely
•2\. Less than four weeks post MI
•3\. Not suitable for revascularization before randomization
•4\. Patients requiring emergency revascularization
•5\. Lack of informed consent